Top 10 Lifestyle Interventions for Glaucoma

#1: Nicotinamide + Pyruvate — Fueling the Optic Nerve

Why This Matters for Glaucoma

Nicotinamide (Vitamin B3) and pyruvate target one of the most important—and often overlooked—drivers of glaucoma: cellular energy failure in the optic nerve.

Together, they may help support retinal ganglion cell survival and function.

While eye pressure is important, glaucoma is increasingly understood as a disease of:

  • Mitochondrial dysfunction
  • Metabolic stress
  • Energy depletion in retinal ganglion cells

These cells are among the most energy-demanding in the body.
👉 When energy production fails, the optic nerve becomes vulnerable—even at normal pressures.

What the Science Shows

  • Nicotinamide restores cellular energy pathways:
    Nicotinamide is a precursor to NAD⁺, a molecule essential for mitochondrial function. In preclinical models, supplementation has been shown to prevent retinal ganglion cell loss and protect against glaucoma-related damage.

  • Human studies show functional improvement:
    Early clinical trials suggest that high-dose nicotinamide may lead to improvements in retinal function in patients with glaucoma, as measured by electrophysiologic testing.

  • Pyruvate supports mitochondrial metabolism:
    Pyruvate plays a direct role in cellular energy production and may help buffer metabolic stress and oxidative damage in retinal cells.

  • Combination approach may be synergistic:
    Targeting multiple steps in the energy pathway (NAD⁺ production + mitochondrial fuel) may provide more robust neuroprotection than single-agent approaches.

Why Does This Help?

Nicotinamide and pyruvate work together to:

  • Restore NAD⁺ levels, critical for cellular metabolism
  • Support mitochondrial energy production (ATP)
  • Reduce oxidative stress and metabolic strain
  • Improve resilience of retinal ganglion cells

👉 This directly targets a root cause of optic nerve degeneration—not just pressure.

Woman eating cereal with Glaucovite glaucoma vitamins in a kitchen setting.

What Should You Do?

  • Consider targeted supplementation that addresses:NAD⁺ metabolism (nicotinamide)Mitochondrial support (pyruvate)

  • Look for formulations designed specifically for optic nerve health, not general wellness

What to Watch For

  • Effective doses used in studies are often higher than standard multivitamins

  • Not all supplements are formulated with glaucoma-specific dosing or combinations

  • Should be discussed with a physician, especially at higher doses

Bottom Line

Nicotinamide and pyruvate represent one of the most promising and mechanistically grounded approaches in glaucoma care today.

👉 Rather than focusing only on eye pressure, this strategy targets the underlying energy failure that contributes to optic nerve damage.

Glaucovite is currently the only supplement specifically formulated to address this pathway in glaucoma—combining evidence-based ingredients aimed at supporting mitochondrial function and retinal ganglion cell health.

👉 For patients looking to go beyond traditional approaches, this may be one of the most important areas to consider.

Key References

  1. De Moraes CG, John SWM, Williams PA, et al. Nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma: a phase 2 randomized clinical trial. JAMA Ophthalmol. 2022;140(1):11-18. doi:10.1001/jamaophthalmol.2021.4576 
  2. Tribble JR, Otmani A, Sun S, et al. Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction. Redox Biol. 2021;43:101988. doi:10.1016/j.redox.2021.101988 
  3. Williams PA, Harder JM, Foxworth NE, et al. Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science. 2017;355(6326):756-760. doi:10.1126/science.aal0092 
  4. Hui F, Tang J, Williams PA, et al. Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial. Clin Exp Ophthalmol. 2020;48(7):903-914. doi:10.1111/ceo.13818 
  5. Fahmideh F, Marchesi N, Barbieri A, Govoni S, Pascale A. Non-drug interventions in glaucoma: Putative roles for lifestyle, diet and nutritional supplements. Surv Ophthalmol. 2022 May-Jun;67(3):675-696. doi:10.1016/j.survophthal.2021.09.002 
  6. Kouassi Nzoughet J, Chao de la Barca JM, Guehlouz K, et al. Nicotinamide deficiency in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2019;60(7):2509-2514. doi:10.1167/iovs.19-27099 
Return to Overview of Lifestyle Interventions for Glaucoma